Skip to main content

Table 4 Predictors of longitudinal EQ-5D index and EQ-VAS score in HCV participants by univariable GEE estimation

From: Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China

Parameter

EQ-5D Index

EQ-VAS Score

β

SE

p value

95% CI

β

SE

p value

95% CI

Gender (Ref: Female)

        

 Male

0.025

0.012

0.033

0.002, 0.047

3.462

0.928

0.000

1.643, 5.281

Age (Ref: ≥ 60y)

        

 18–39

0.074

0.016

0.000

0.042, 0.105

8.459

1.306

0.000

5.900, 11.019

 40–59

0.029

0.017

0.082

-0.004, 0.062

3.166

1.280

0.013

0.658, 5.674

Residence (Ref: West)

        

 Central

0.037

0.018

0.036

0.002, 0.071

1.681

1.397

0.229

-1.058, 4.419

 East

0.016

0.019

0.541

-0.025, 0.049

-1.379

1.371

0.314

-4.065, 1.308

 North

-0.019

0.022

0.378

-0.062, 0.024

-3.207

1.599

0.045

-6.342, -0.073

 South

0.028

0.018

0.118

-0.007, 0.062

1.936

1.352

0.152

-0.714, 4.587

Marital status (Ref: Single)

        

 Separated / Divorced / Widowed

-0.060

0.027

0.029

-0.113, -0.006

-10.961

2.412

0.000

-15.689, -6.233

 Married

-0.031

0.016

0.060

-0.063, 0.001

-4.372

1.208

0.000

-6.740, -2.004

Occupation (Ref: Unemployed)

        

 Blue collar

-0.021

0.012

0.085

-0.046, 0.003

-1.306

1.398

0.350

-4.047, 1.435

 White Collar

-0.015

0.013

0.234

-0.039, 0.010

-0.781

1.469

0.595

-3.660, 2.099

 Other

-0.033

0.018

0.068

-0.068, 0.002

-1.709

1.825

0.349

-5.286, 1.868

Education (Ref: Primary School)

        

 Junior school

0.040

0.026

0.124

-0.011, 0.091

3.261

1.556

0.036

0.211, 6.311

 High-school

0.026

0.026

0.316

-0.025, 0.077

3.255

1.586

0.040

0.147, 6.364

 College graduate

0.050

0.025

0.047

0.001, 0.100

4.852

1.493

0.001

1.926, 7.778

Income (Ref: < 2000 RMB)

        

 2000–4999 RMB

-0.012

0.013

0.370

-0.037, 0.014

0.424

0.996

0.670

-1.529, 2.377

 5000–7999 RMB

0.001

0.021

0.967

-0.041, 0.043

-0.805

2.086

0.700

-4.892, 3.283

 8000–9999 RMB

0.064

0.007

0.000

0.049, 0.078

7.329

2.511

0.004

2.408, 12.251

 ≥10,000 RMB

0.047

0.013

0.001

0.020, 0.074

3.951

3.046

0.195

-2.020, 9.921

Route of HCV acquisition

        

 Blood Transfusion

-0.005

0.009

0.583

-0.022, 0.012

-0.314

0.558

0.574

-1.406, 0.779

 Intravenous drug abuse

0.001

0.025

0.972

-0.048, 0.050

-1.936

1.333

0.147

-4.550, 0.678

 Dental treatment

0.006

0.009

0.465

-0.011, 0.023

0.864

0.666

0.195

-0.442, 2.170

 Other

0.003

0.011

0.813

-0.019, 0.025

0.603

0.642

0.347

-0.655, 1.861

Symptoms of discomfort (Ref: ≥ 2)

        

 0

0.053

0.040

0.194

-0.027, 0.132

4.391

2.638

0.096

-0.779, 9.561

 1

0.011

0.044

0.806

-0.076, 0.097

-1.517

2.974

0.610

-7.347, 4.312

Extrahepatic manifestation (Ref: No)

-0.022

0.022

0.325

-0.066, 0.022

-2.470

1.755

0.159

-5.909, 0.970

Cirrhosis (Ref: No)

-0.061

0.031

0.045

-0.122, -0.001

-5.741

1.640

0.000

-8.955, -2.526

Beck’s Depression Score (Ref: < 17)

-0.043

0.017

0.013

-0.077, -0.009

-3.324

2.120

0.117

-7.479, 0.832

HCV Genotype (Ref: Else)

        

 1

-0.028

0.016

0.073

-0.060, 0.003

-4.467

1.220

0.000

-6.857, -2.076

 2

-0.016

0.013

0.225

-0.042, 0.010

-2.976

1.122

0.008

-5.175, − 0.777

Log10 HCV RNA, IU/mL

0.001

0.005

0.860

-0.009, 0.011

0.001

0.005

0.860

-0.009, 0.011

SVR24 (Ref: No)

0.049

0.008

0.000

0.033, 0.065

5.933

0.564

0.000

4.827, 7.040

Duration of follow-up, month

-0.019

0.007

0.010

-0.033, -0.004

-1.521

0.531

0.004

-2.562, -0.480